Gene · 2548
Papers2,709
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,709
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Implementing a Tiered Genetic Testing Strategy for Muscular Dystrophies in Morocco: From Targeted Assays to Exome Sequencing. | Mol Genet Genomic Med | 2026 | 41742649 | PubTator, text mining | PubMed |
| Generation and characterization of a novel Gaa compound heterozygous mouse model recapitulating human Pompe disease. | Orphanet J Rare Dis | 2026 | 41742217 | PubTator, text mining | PubMed |
| Lactylation profiling reveals novel biomarkers and immune interactions in pancreatic cancer. | Transl Oncol | 2026 | 41734473 | PubTator, text mining | PubMed |
| Glycogen storage disease type IX: Long-term follow-up of 52 patients from three European countries. | Mol Genet Metab Rep | 2026 | 41732189 | PubTator, text mining | PubMed |
| Short-Term Intensive Avalglucosidase Alfa Regimen in Late-Diagnosed Infantile Pompe Disease: A Case Report. | Reports (MDPI) | 2026 | 41718282 | PubTator, text mining | PubMed |
| Cell modeling and rescue of a novel noncoding genetic cause of glycogen storage disease IX. | Genet Med Open | 2026 | 41716687 | PubTator, text mining | PubMed |
| Clinicopathologic Correlates: Progressive Downbeat Nystagmus in Spinocerebellar Ataxia Type 27B. | J Neuroophthalmol | 2026 | 41700956 | PubTator, text mining | PubMed |
| A roadmap for a patient-centred approach to Pompe disease management. | J Neurol | 2026 | 41689635 | PubTator, text mining | PubMed |
| Improving access to rare disease diagnostics in Africa: insights from a multinational pilot study. | Orphanet J Rare Dis | 2026 | 41645220 | PubTator, text mining | PubMed |
| Integrated co-expression analysis of host-parasite transcriptomes reveals mechanisms of host modulation in an ant-cestode system. | BMC Genomics | 2026 | 41620683 | PubTator, text mining | PubMed |
| Targeted Carrier Screening for Thalassemia, Hereditary Deafness, and Spinal Muscular Atrophy: A Feasible Approach for Preventing Birth Defects in China's Community Healthcare System. | Mol Genet Genomic Med | 2026 | 41566141 | PubTator, text mining | PubMed |
| GMPPB-CDG Results in Lysosomal Dysfunction and Acid Alpha-Glucosidase Deficiency. | J Inherit Metab Dis | 2026 | 41554119 | PubTator, text mining | PubMed |
| Early initiation of enzyme replacement therapy as facilitated by newborn screening improves health outcomes among patients with infantile-onset Pompe disease. | Genet Med Open | 2026 | 41536902 | PubTator, text mining | PubMed |
| Porcine serum maltase-glucoamylase: structure, kinetics, and inhibition. | J Enzyme Inhib Med Chem | 2026 | 41534875 | PubTator, text mining | PubMed |
| Glycophagy: molecular mechanisms, regulatory signals, and disease associations. | Autophagy Rep | 2026 | 41522193 | PubTator, text mining | PubMed |
| Rapid Regression of Myocardial Hypertrophy with First-Line Avalglucosidase Alfa in Infantile-Onset Pompe Disease: A Case Report. | Pediatr Cardiol | 2026 | 41511518 | PubTator, text mining | PubMed |
| Clinical, Genetic, and Imaging Characteristics of SCA27B: Insights from a Large Dutch Cohort. | Mov Disord | 2026 | 41504274 | PubTator, text mining | PubMed |
| Integrative Human Genomic and Pharmacological Analyses Identify CACNB4 as a Druggable Target for Periodontitis. | J Periodontal Res | 2026 | 41498379 | PubTator, text mining | PubMed |
| Recommendations for the diagnosis, treatment, and follow-up of late-onset Pompe disease. | Neurologia (Engl Ed) | 2026 | 41453611 | PubTator, text mining | PubMed |
| Evaluation of Experienced Clinical Events in Pompe Disease Based on Real-life Data. | Neuropediatrics | 2026 | 41453391 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2548/papers?page=3